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Multiple synaptic adhesion molecules govern syn-
apse formation. Here, we propose calsyntenin-3/
alcadein-b as a synapse organizer that specifically
induces presynaptic differentiation in heterologous
synapse-formation assays. Calsyntenin-3 (CST-3) is
highly expressed during various postnatal periods
of mouse brain development. The simultaneous
knockdown of all three CSTs, but not CST-3 alone,
decreases inhibitory, but not excitatory, synapse
densities in cultured hippocampal neurons. More-
over, the knockdown of CSTs specifically reduces
inhibitory synaptic transmission in vitro and in vivo.
Remarkably, the loss of CSTs induces a concomitant
decrease in neuron soma size in a non-cell-autono-
mous manner. Furthermore, a-neurexins (a-Nrxs)
are components of a CST-3 complex involved in
CST-3-mediated presynaptic differentiation. How-
ever, CST-3 does not directly bind to Nrxs. Viewed
together, these data suggest that the three CSTs
redundantly regulate inhibitory synapse formation,
inhibitory synapse function, and neuron develop-
ment in concert with Nrxs.
INTRODUCTION
Synaptic cell-adhesion molecules (CAMs) are major synapse
organizers that initiate the cell-type-specific formation of
nascent synaptic contacts and recruit the pre- and postsynaptic
protein complexes required for proper synaptic signaling
(Missler et al., 2012). The list of synaptic CAMs has rapidly
grown, largely reflecting the development of the heterologous1096 Cell Reports 6, 1096–1109, March 27, 2014 ª2014 The Authorssynapse formation assay (Biederer and Scheiffele, 2007). Neuro-
ligins (NLs), SynCAMs, netrin-G ligands, SALM3 and SALM5,
leucine-rich repeat transmembrane proteins (LRRTMs), and
Slit- and Trk-like (Slitrks) proteins are among the synaptogenic
CAMs with established synaptic functions (Missler et al., 2012;
Su¨dhof, 2008; Um and Ko, 2013). However, considering the
number of neuronal synapses and neural circuits in the brain, it
is reasonable to propose that additional synaptogenic CAMs
remain undefined.
Calsyntenins (CSTs), also called alcadeins, are members of
the cadherin superfamily (Araki et al., 2003; Vogt et al., 2001).
Originally identified from spinal-cord neurons (Vogt et al.,
2001), CSTs are type I transmembrane proteins with extracellular
domains containing two cadherin repeats and a laminin-a,
neurexin, and sex hormone-binding globulin (LNS) domain.
These proteins comprise three members: CST-1 (alcadein-a),
CST-2 (alcadein-g), and CST-3 (alcadein-b), and a single ortho-
log has also been identified in Caenorhabditis elegans (CASY-1
or CDH11) and Drosophila melanogaster (Cals) (Ikeda et al.,
2008; Pettitt, 2005). CSTs are widely expressed in the CNS
(Hintsch et al., 2002; Vogt et al., 2001). CST-1 is primarily
expressed in the postsynaptic membranes of pyramidal
neurons, whereas CST-2 and CST-3 are expressed in inhibitory
neurons (Hintsch et al., 2002). Interestingly, CASY-1 is essential
for chemotaxis-associated learning (Hoerndli et al., 2009; Ikeda
et al., 2008), and CST-2 polymorphisms have been associated
with human memory performance (Papassotiropoulos et al.,
2006). In addition, CSTs dock vesicular cargo to kinesin-1,
thereby determining the identity of transported cargo molecules
(Araki et al., 2007; Konecna et al., 2006; Maruta et al., 2012;
Vagnoni et al., 2011). More specifically, CST-1 mediates the
transport of amyloid precursor protein (APP) via binding to
X11/Mint and protects this protein from proteolytic processing
during axonal transport (Suzuki et al., 2006; Vagnoni et al.,
2012). Intriguingly, several CST peptides have been frequently
Figure 1. CST-3 Induces Presynaptic Differentiation inHeterologous
Synapse-Formation Assays
(A) CST-3 promotes the formation of excitatory and inhibitory presynapses in
heterologous synapse-formation assays. Rat hippocampal neurons were
cocultured for 3 days (DIV10–DIV13) with HEK293T cells expressing EGFP
alone (control) or coexpressing EGFP and N-terminally HA-tagged CST-1
extracellular fragment (CST-1), CST-2 extracellular fragment (CST-2), CST-3
extracellular fragment (CST-3), or an mVenus-fusion protein of neuroligin-2
(NL2). The panels show representative immunofluorescence images of
cocultures stained with antibodies to EGFP (green) and various presynaptic
(VGLUT1, GAD67) and postsynaptic (PSD-95) markers (red). Coincident green
and red signals are shown in yellow. The scale bar represents 20 mm (applies to
all images).
(B) Quantitation of the heterologous synapse-formation activity of CST-1,
CST-2, CST-3, and NL2. To quantify the experiments described in (A), the ratio
Ceidentified in the cerebrospinal fluid of Alzheimer’s disease (AD)
patients (Ringman et al., 2012; Yin et al., 2009), and CST-3 accu-
mulates in dystrophic neurites surrounding amyloid-b (Ab)
plaques (Uchida et al., 2013). Moreover, CST-1 regulates Ab
production through the regulation of APP transport at axons
(Vagnoni et al., 2012). These data suggest that CST-associated
molecular pathways might contribute to the pathogenic mecha-
nisms underlying AD. However, the synaptic functions of CSTs
have not been investigated.
Here, we characterized the effects of CSTs on the structure
and function of synapses in hippocampal and somatosensory
cortical layer II/III neurons in vivo. CST-3 specifically induced
presynaptic differentiation. The simultaneous knockdown of all
three CSTs, but not a single CST isoform, decreased inhibitory
synapse densities in cultured hippocampal neurons. Strikingly,
CST-deficient neurons were morphologically smaller, and the
neuronal phenotype was completely restored through the exog-
enous expression of full-length CST proteins. Furthermore, the
frequency of miniature inhibitory, but not excitatory, postsyn-
aptic currents was specifically reduced in CST-deficient cultured
hippocampal and somatosensory cortical neurons. Moreover,
we observed that CST-3 forms functional (but not physical)
complexes with Nrxs. These data suggest that CST-3 is a synap-
togenic adhesion molecule that forms functional complexes with
Nrxs to regulate inhibitory synapse function.
RESULTS
Using heterologous synapse-formation assays with plasmid
vectors expressing the entire extracellular region of cell-surface
proteins exhibiting brain-specific expression (Table S1), we
screened for novel synaptogenic molecules that induce presyn-
aptic differentiation (Biederer and Scheiffele, 2007). The results
revealed that LRRTMs, Slitrks, and TrkC act at the axons of
cocultured neurons to specifically trigger presynaptic differenti-
ation (Ko et al., 2009a; Yim et al., 2013). In addition, the expres-
sion of CST-3 also showed synaptogenic activity.
CST-3 Triggers Presynaptic Differentiation
To determine the synaptic function(s) of CST-3, we first exam-
ined whether all three CSTs trigger presynaptic differentiation
in heterologous synapse-formation assays using human embry-
onic kidney 293T (HEK293T) cells expressing each CST protein.
To maximize the cell-surface expression of CST proteins, we
generated plasmids for the expression of full extracellular frag-
ments of CSTs. CST-3, but not CST-1 or CST-2, strongly
induced synapsin clustering (Figures 1A and 1B). In parallelof the synaptic marker staining to EGFP fluorescence (from absolute red and
green fluorescence values) was measured. All data are shown as means ±
SEMs (3*p < 0.001, assessed using ANOVA with Tukey’s test; n denotes the
total number of HEK293T cells analyzed, as follows: control/synapsin, n = 18;
CST-1/synapsin, n = 21; CST-2/synapsin, n = 17; CST-3/synapsin, n = 16;
NL2/synapsin, n = 14; control/VGLUT1, n = 22; CST-1/VGLUT1, n = 17; CST-2/
VGLUT1, n = 15; CST-3/VGLUT1, n = 15; NL2/VGLUT1, n = 16; control/
GAD67, n = 15; CST-1/GAD67, n = 15; CST-2/GAD67, n = 14; CST-3/GAD67,
n = 15; NL2/GAD67, n = 14; control/PSD-95, n = 15; CST-1/PSD-95, n = 16;
CST-2/PSD-95, n = 17; CST-3/PSD-95, n = 16; and NL2/PSD-95, n = 15).
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Figure 2. N-Terminal Cadherin Repeats Are Required for the
Synaptogenic Activities of CST-3
(A) Diagrams of the CST-3 variants used in heterologous synapse-formation
assays. The full extracellular region of CST-3 (Ecto-full) carrying an HA epitope
inserted after the signal peptide sequencewas cloned into the pDisplay vector.
CST-3 fragments carrying the following extracellular regions were also
prepared as pDisplay vectors: Cad+LNS, a CST-3 fragment containing
cadherin repeats and an LNS domain; LNS+linker, a CST-3 fragment
containing the LNS domain and the linker region between an LNS domain and
a transmembrane segment; Cad repeats, a CST-3 fragment containing two
cadherin repeats; LNS, a CST-3 fragment containing the LNS domain; Cad
repeat 1, a CST-3 fragment containing the first cadherin repeat; and Cad
repeat 2, a CST-3 fragment containing the second cadherin repeat.
(B and C) Synaptogenic activity of various CST-3 constructs (described in A)
in heterologous synapse-formation assays. Representative immunofluores-
cence images of cocultures stained with antibodies to GFP (green) and syn-
apsin (red). Coincident signals are shown in yellow. The scale bar represents
20 mm (applies to all images; B). Quantitation of heterologous synapse-forma-
tion assays (C), measured as the ratio of synapsin to GFP fluorescence signals.
The dashed lines correspond to control values, used as the baseline. The data
are shown as the means ± SEMs (3*p < 0.001, assessed using ANOVA with
Tukey’s test; n denotes the total number of HEK293T cells analyzed, as follows:
control, n = 15; Ecto-Full, n = 17; Cad+LNS, n = 17; LNS+linker, n = 16; Cad
repeats, n = 14; LNS, n = 15; Cad repeat 19, n = 16; and Cad repeat 2, n = 16).
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CSTs, did not induce synaptic clustering (data not shown).
Similar to NL-2 (positive control), CST-3 induced the synaptic
clustering of both the excitatory presynaptic marker vesicular
glutamate transport 1 (VGLUT1) and the inhibitory presynaptic
marker glutamic acid decarboxylase, 67 kDa (GAD67), but not
the excitatory postsynaptic marker postsynaptic density,
95 kDa (PSD-95) (Figures 1A and 1B). These results suggest
that CST-3 is a postsynaptogenic factor that induces presynap-
tic differentiation.
N-Terminal Cadherin Repeats Are Essential for the
Presynapse-Inducing Activities of CST-3
CSTs possess two extracellular cadherin motifs (Cad repeats), a
single LG/LNS domain, a transmembrane segment, and a short
intracellular region comprising X11- and kinesin-binding sites
(Araki et al., 2003; Vogt et al., 2001). To determine the domains
responsible for CST-3 synaptogenic activity, we performed
heterologous synapse-formation assays using deletion
constructs of CST-3 extracellular fragments (Figure 2A). Only
CST-3 mutants containing both Cad repeats exhibited full
synaptogenic activity in heterologous synapse-formation assays
(Figures 2B and 2C). Cadherin repeats typically mediate extra-
cellular Ca2+-dependent homophilic adhesion; thus, we exam-
ined whether CSTs mediate homo- or heterophilic adhesion
between CST family members using cell-adhesion and cell-
surface-labeling assays (Figure S1). We observed that CSTs
showed no homo- or heterophilic adhesion activities, suggesting
the existence of unidentified presynaptic ligand(s) for CSTs.
CST-3 mRNA and Protein Expression Patterns
Previous northern blot and in situ hybridization analyses of CSTs
revealed that these proteins are located in postsynaptic mem-
branes and are widely expressed in multiple brain regions
(Hintsch et al., 2002; Vogt et al., 2001). Intriguingly, although
CST-1 is enriched in axonal growth cone vesicles in the devel-
oping brain, this protein is restricted to the postsynaptic mem-
branes of excitatory and inhibitory synapses (Konecna et al.,
2006; Vogt et al., 2001). To determine whether other CST iso-
forms are also expressed in the developing brain, we performed
in situ hybridization using mouse brain sections obtained from
various embryonic and postnatal developmental stages (Fig-
ure 3A). CST-1 mRNA was expressed through the entire body
and more abundantly in the CNS (Figure 3A), consistent with
the previously reported CST-1 expression pattern (Vogt et al.,
2001). In contrast, the distribution of CST-2 and CST-3 in
E16–E18 mice was restricted to the CNS. In adult mouse
brains, a strong CST-3 mRNA signal was observed in various
brain areas, whereas CST-2 mRNA was locally distributed to
brain regions, including the hippocampus and olfactory bulb
(Figure 3A).
To confirm the results obtained in the in situ hybridization anal-
ysis, we generated CST polyclonal CST-1/CST-2 antibodies
(pan-antibody; JK010) and a CST-3-specific antibody (JK001)
(Figures 3B and 3C). The CST-3 antibody (JK001) was used to
confirm the authenticity of the immunoreactive signals using
CST-3 knockout mouse lysates (Figure 3D). The expression of
CST-1/CST-2 proteins abruptly increased between postnatal
day 7 (P7) and P14, whereas CST-3 protein was steadily ex-
pressed throughout the postnatal development of mouse brains
(Figure 3E). However, these antibodies were not suitable for
immunocytochemistry; thus, we were unable to determine the
synaptic localization of CSTs in cultured neurons (data not
shown). All three CST proteins were significantly expressed
(although not clearly enriched) in the PSD fraction (Figure 3F),
consistent with previously reported biochemical data (Vogt
et al., 2001). Taken together, these results indicate that CST-3
is a PSD-localized synaptogenic adhesion molecule.
The Simultaneous Knockdown of All Three CSTs
Decreases Inhibitory Synapse Density in Cultured
Neurons
To determine whether CSTs are required for the maintenance of
synapse structure, we generated a series of knockdown (KD)
lentiviral vectors expressing short hairpin RNA (shRNA) targeting
individual CSTs. Subsequently, we infected cultured mouse
cortical neurons with these vectors and assessed the endoge-
nous target mRNA levels using quantitative real-time RT-PCR
(Figures 4A and 4B). The shRNA suppressed endogenous
mRNA expression 90% for CST-1, 80% for CST-2, and
85% for CST-3 (Figure 4B). We next investigated whether the
single KD of CST-1, CST-2, or CST-3 altered the synapse
number in cultured mouse hippocampal neurons. To this end,
we infected cultured neurons at 3 days in vitro (DIV3) with lenti-
viruses expressing only enhanced GFP (EGFP) (control) or coex-
pressed EGFPwith shRNAs against CST-1 (J73), CST-2 (J76), or
CST-3 (J81). In addition, we immunostained neurons at DIV14
for synapsin and microtubule-associated protein 2 (MAP2) to
visualize the entire somatodendritic architecture of the infected
neurons (Figure S2A). We observed that single KD of each CST
did not alter synapse density, synapse size, synapse strength,
or soma size (Figures S2B–S2E), suggesting that either CSTs
are not required for synapse maintenance or that CSTs are func-
tionally redundant. To examine the potential functional redun-
dancy of CSTs, we generated a triple-KD vector (CST-TKD)
containing three human polymerase III promoters to drive the
expression of shRNAs against all three CSTs and a ubiquitin pro-
moter to drive expression of EGFP, facilitating the visualization of
infected or transfected neurons (Figure 4A).
Using the CST-TKD vector, which successfully suppressed
the mRNA levels of all three CSTs (Figure 4C), we examined
whether CSTs are functionally redundant and essential for syn-
apse maintenance in cultured hippocampal neurons (Figures 4
and S3). Strikingly, CST-TKD significantly decreased the number
of inhibitory synapses, assessed using inhibitory synaptic
markers (GAD67 and gephyrin; Figures 4D, 4E, and S3).
CST-TKD also significantly reduced the number of excitatory
presynaptic puncta (labeled by VGLUT1), but not excitatory
postsynaptic puncta (labeled by Homer1) (Figures 4D, 4E, and
S3). These data suggest that CST-TKD preferentially alters inhib-
itory, but not excitatory, synapse structure in cultured hippocam-
pal neurons. As previously reported, an LRRTM1 and LRRTM2
double-KD vector (LRRTM-DKD) did not alter the synapse den-
sity (Figures 4D and 4E; Ko et al., 2011). We also transfected
cultured neurons at DIV8 with CST-TKD or an empty lentiviral
shRNA vector (control) and immunostained neurons at DIV14Cefor synapsin and EGFP (Figure S4). The introduction of the
CST-TKD vector induced a modest but significant decrease in
synapse number without changing synapse or soma size or
any spine parameters (number, width, or length) (Figures S4A–
S4G). Taken together, these results suggest that CSTs redun-
dantly maintain synapses in cultured hippocampal neurons.
KD of CSTs Decreases the Soma Size of Cultured
Hippocampal Neurons
An analysis of cultured mouse neurons infected with CST-TKD
lentiviruses showed a dramatic reduction in the soma size of
CST-TKD-infected neurons compared with control or LRRTM-
DKD-infected neurons (Figures 4D and 4F). Moreover, electro-
physiology recordings in cultured hippocampal neurons revealed
that CST-TKD caused a significant decrease in membrane
capacitance (Cm) and a concomitant increase in input resistance
(Rm) (Figures S5A and S5B). These results imply that CSTs might
stimulate the development of hippocampal neurons during the
early stages of development. To examine this hypothesis, we in-
fected hippocampal neurons with control or CST-TKD viruses at
DIV3 and measured neuron soma size during cultured neuron
development every other day from DIV5 to DIV13 (Figure S6).
We observed that the soma size of cultured neurons infected
with control viruses abruptly increased between DIV7 and DIV9,
whereas no increase in the soma size of neurons infected with
CST-TKDwas observed (Figure S6), suggesting that a deficiency
of CST proteins arrests neuronal development, which manifests
as an absence of growth in the cell-body size. In contrast, the
soma size of neurons transfected with CST-TKDwas unchanged
(Figure S4D), indicating that the effects of CSTs in regulating
neuronal soma size were non-cell autonomous. Because the
simultaneous KD of multiple proteins occasionally leads to con-
founding, nonspecific phenotypes, we further examined whether
the decreases in soma size and synapse number induced
by CST-TKD could be rescued through the coexpression of
shRNA-resistant CSTs (Figures 4G–4I). We observed that
superinfectionwith bothCST-1 andCST-3 completely eliminated
the deficits in both soma size and synapse density observed with
CST-TKD (Figures 4G–4I). Strikingly, the superinfection of either
CST-1 or CST-3 alone did not restore the deficits in soma size
but did restore the deficits in synapse number, suggesting that
all three CSTs contribute to the growth of the neuronal cell
body in a concerted manner. We also noted that the lentiviral
expression of CST-1, CST-2, or CST-3 alone did not affect syn-
apse density (Figure 4H). Thus, we considered whether our lenti-
viral expression system yielded lower expression levels of CSTs
than chemical transfection. We compared the effect of express-
ing CST-3 in cultured hippocampal neurons using a CST-3 lenti-
viral construct with CST-3 expression plasmid transfection using
a Ca2+-phosphate/DNA coprecipitation method (Figures S7A–
S7C). The overexpression of CST-3 by chemical transfection
significantly increased the synapse density, whereas lentiviral
CST-3 expression did not, implying that the CST-3 expression
level per se is critical for synapse maintenance (Figures S7A–
S7C). Using the CST-3 wild-type (WT) expression vector, we
found that CST-3 WT exerted synaptogenic activities in gain-
of-function assays. CSTs are cleaved by a-secretases (Maruta
et al., 2012), raising questions concerning the expression of thesell Reports 6, 1096–1109, March 27, 2014 ª2014 The Authors 1099
Figure 3. Expressions of CSTs in Mouse Brains
(A) CST mRNA distribution patterns in the developing and adult mouse brains. Sections from E16, E18, P7, P14, P21, and P48 (adult) mouse brains were probed
with CST-1, CST-2, and CST-3 cRNAs. The scale bar represents 5 mm. Cb, cerebellum; Ctx, cerebral cortex; Hc, hippocampus; OB, olfactory bulb.
(B) Biochemical characterization of the CST antibodies used in this study. Immunoblot analyses of CST antibodies using mouse-brain synaptosomes and lysates
fromHEK293T cells, untransfected or transfected with CST-2 or CST-3 expression vector. JK010 is reactive to both CST-1 andCST-2 proteins, whereas JK001 is
specific to CST-3. Br, brain; P2, crude synaptosomes; Unt, untransfected HEK293T cell lysates.
(C) Cross-reactivity of the CST antibodies. HEK293T cells, untransfected or transfected with the indicated CST expression vectors, were immunoblotted with
CST-1/CST-2 (JK010) and CST-3 (JK001) antibodies. The expression of HA-tagged CST vectors was confirmed through immunoblotting with HA antibodies. An
a-tubulin antibody was used for normalization.
(legend continued on next page)
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CSTconstructs on the surfaceof heterologous cells andneurons.
We found that, although themajority ofCSTsare secreted into the
cell-culture medium, 10%–35% of CSTs are expressed on the
surface of both HEK293T cells and cultured neurons (Figures
S7D–S7G; data not shown), suggesting that surface-exposed
CSTs remain competent.
KD of CSTs Leads to a Reduction in Inhibitory, but Not
Excitatory, Synaptic Transmission In Vitro and In Vivo
To determine whether the changes in anatomical synapse
numbers presented in Figure 4 reflect changes in the number
of functional synapses, we examined synaptic transmission in
mouse cultured hippocampal neurons infected with control or
CST-TKD viruses (Figures S5C–S5H). Strikingly, measurements
of miniature excitatory postsynaptic currents (mEPSCs) showed
that CST-TKD did not alter excitatory synaptic transmission
(Figures S5C, S5E, and S5F). In contrast, CST-TKD caused a
significant decrease in the frequency, but not the amplitude, of
miniature inhibitory postsynaptic currents (mIPSCs) (Figures
S5D, S5G, and S5H). These results suggest that, although
CSTs are required for the maintenance of both excitatory and
inhibitory synapses, thesemolecules are predominantly involved
in regulating inhibitory synaptic functions.
To further corroborate the in vitro electrophysiological results,
we examined the effect of CSTs KD in somatosensory cortical
layer II/III neurons in vivo through the in utero electroporation
at E15 and analysis at P14–P19 (Figure 5A). Similar to the results
obtained with cultured neurons, CST-TKD specifically reduced
the frequency of mIPSCs (Figures 5B–5D) without altering the
frequency or amplitude of mEPSCs (Figures 5E–5G). Unexpect-
edly, CST-TKD increased the amplitude of mIPSCs. The expla-
nation for this observation is not clear but might reflect the
decreased soma size of CST-deficient neurons or increased
gephyrin puncta intensity (see Figures 4, 5J, and 5K; data not
shown). We detected no changes in the paired-pulse ratio
(PPR) of inhibitory IPSCs in CST-TKD neurons, indicating no
effects on presynaptic functions (Figures 5H and 5I). Consistent
with the cultured neuron morphology, the soma sizes of CST-
TKD neurons were smaller, as demonstrated by a decrease in
membrane capacitance and a trend toward increased input
resistance (Figures 5J and 5K). Taken together, these results
indicate that CSTs are required for inhibitory synaptic transmis-
sion in vitro and in vivo.
CST-3 Forms Functional Complexes with Nrxs to Induce
Presynapse Development
CSTs contain two extracellular cadherin repeats and an LNS
domain, and CST-3 displays synaptogenic activity, inducing
presynaptic differentiation in heterologous synapse-formation
assays (Figures 1 and 2). To identify proteins that interact with
the extracellular regions of CST-3, we used affinity chromatog-(D) Authenticity of the CST-3 antibody (JK001). P2 fractions from brains of wild-typ
antibodies. An a-tubulin antibody was used for normalization.
(E) The expression of CST proteins during development. E, embryonic day; P, po
(F) Localization of CST proteins in PSD fractions. The proteins from each mou
antibodies. P2, crude synaptosomal fraction; S2, cytosolic and light membrane fr
Fraction, Synaptosomal fraction.
Ceraphy, employing recombinant CST-3 fusion proteins expressed
from HEK293T cells transfected with immunoglobulin (Ig)-CST-3
comprising the entire extracellular sequence of CST-3 fused to
the Fc-domain of human IgG to probe solubilized mouse brains
(Figure 6A). Mass spectrometry analyses of Coomassie-blue-
stained gels revealed multiple bands that were not observed in
the negative control lane (IgC; Figure 6B). Among the identified
peptides, multiple peptides were derived from cell-surface pro-
teins, such as Nrxs (Figures 6C–6F; Tables 1 and S2). We asked
whether Nrxs are required for the synaptogenic activities of
CST-3. We infected cultured neurons with lentiviruses express-
ing either an empty shRNA vector (control) or a triple-KD shRNA
construct for Nrxs (Nrx-TKD). Subsequently, we performed
heterologous synapse-formation assays using infected neurons
and HEK293T cells expressing CST-3, NL1 (positive control), or
Slitrk1 (negative control) (Figures 6G and 6H). Upon Nrx-TKD, we
observed the absence of CST-3-induced synapsin clustering on
contacting axons of cocultured hippocampal neurons. In parallel
experiments, Nrx-TKD abolished the synaptogenic activities of
NL1, but not those of Slitrk1, consistent with the notion that
Nrxs are presynaptic receptors for NL1 (note that PTPd and
PTPs are presynaptic ligands for Slitrk1; see Gokce and Su¨dhof
(2013) and Yim et al. (2013). Taken together, these results indi-
cate that CST-3 forms a functional complex with Nrxs.
CST-3 Does Not Directly Interact with Nrxs
The fact that presynaptic Nrxs are functional receptors for CST-3
(Figure 6) prompted us to examine whether Nrxs directly bind to
CST-3. First, we employed cell-surface-labeling assays to deter-
mine whether CST-3 directly binds to both a- and b-Nrxs
(Figures 7A and 7B). We examined the binding of recombinant
Ig-fusion proteins of Nrx-1a and -1b lacking an insert in splice
site (SS) no. 4 (Ig-Nrx1aSS4 and Ig-Nrx1bSS4, respectively) to
HEK293T cells expressing hemagglutinin (HA)-tagged CSTs.
Surprisingly, we observed no binding of the Ig-Nrx1 fusion pro-
teins with HA-CSTs in cell-surface-labeling assays (Figure 7A).
Consistent with this observation, we found that the Ig-CST-3
fusion protein did not bind FLAG-tagged Nrxs in cell-surface-
labeling assays (Figure 7B). There are three alternative splicing
sites unique to a-Nrxs (Ullrich et al., 1995); thus, we hypothe-
sized that the presence of inserts at any or all of these sites
(SS no. 1, SS no. 2, and SS no. 3) might modulate the binding
between CST-3 and a-Nrxs in a combinatorial manner. To
examine this hypothesis, we generated a series of Nrx-1a con-
structs containing a subset of domains with selected splice
variants (see Figure 7C for schematic diagrams of HA-Nrx-1a
constructs) and analyzed the binding of these proteins to recom-
binant CST-3 using cell-surface-labeling assays (Figure 7D).
Strikingly, any Nrx1a variants showed no robust binding to HA-
CST-3, indicating that Nrx-1a is not a direct ligand for CST-3.
Moreover, neither Nrx-2a nor Nrx-3a interacted with CST-3 ine or CST-3-KOmice were subjected to immunoblot analyses with the indicated
stnatal day. An a-tubulin antibody was used for normalization.
se brain fraction (5 mg) were subjected to immunoblotting with the indicated
action; PSD, postsynaptic density fraction; SynPhys, synaptophysin; Synapto.
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Figure 4. Knockdown of All Three CSTs, but Not Individual CST
Isoform Alone, Reduces Synapse Density and Soma Size in Cultured
Neurons
(A) Schematic diagram of lentiviral shRNA vectors for KD of single CST iso-
forms (denoted CST-SKD) or triple KD of CST-1 to CST-3 (denoted CST-TKD).
1102 Cell Reports 6, 1096–1109, March 27, 2014 ª2014 The Authorscell-surface-labeling assays (Figure 7D). Consistently, we found
that CST-3 Cad did not bind to Nrx1a, suggesting that CST-3
exerts synaptogenic activity through a mechanism independent
of direct binding to Nrxs (Figure 7A). Furthermore, pull-down
experiments using immobilized Nrx-1a and Nrx-1b (Ig-Nrx-
1aSS4 and Ig-Nrx-1bSS4) Ig-fusion proteins with mouse
synaptosomal fractions revealed that both Ig-Nrx-1aSS4 and
Ig-Nrx-1bSS4 effectively captured NL1, but did not bind to
CSTs (Figure 7E), supporting the absence of an interaction of
Nrx with CSTs. Viewed together, these results suggest that(B) KD efficacies of shRNA lentiviruses. Levels of target CST mRNAs (CST-1–
CST-3) were measured by quantitative RT-PCR in cultured mouse cortical
neurons infected at DIV3 with lentiviruses expressing the indicated shRNAs.
The mRNAs were prepared at DIV12 or DIV13. The dotted line represents the
75% KD cutoff level for tests of biological effects.
(C) Measurements of target mRNA levels (CST-1, CST-2, and CST-3) in
cultured cortical neurons as described in (B), except that neurons were
infected with CST-TKD lentiviruses expressing shRNAs targeting CST-1,
CST-2, and CST-3 (described in A). The target mRNAmeasured is color coded
as indicated on the upper right. Dotted line represents the 75% KD cutoff level
for tests of biological effects.
(D) Representative images of cultured hippocampal neurons infected at DIV3
with lentiviruses expressing EGFP alone (control); coexpressing EGFP with
shRNAs against CST-1, CST-2, and CST-3 (CST-TKD); or coexpressing EGFP
with shRNAs against LRRTM1 and LRRTM2 (LRRTM-DKD). Neurons were
analyzed through double immunofluorescence labeling for MAP2 (blue) and
synapsin (red) at DIV14. The scale bar represents 35 mm (applies to all images).
(E and F) Summary graphs of the effects of CST-TKD in neurons on synapse
density (E; measured using synapsin as a general synapsemarker, VGLUT1 as
an excitatory presynaptic marker, GAD67 as an inhibitory presynaptic marker,
Homer1 as an excitatory postsynaptic marker, and gephyrin as an inhibitory
postsynaptic marker) and soma size (F; measured using MAP2 signals). The
data are shown as the means ± SEMs (3*p < 0.001, assessed using ANOVA
with Tukey’s test; 2 to 3 dendrites per transfected neuron were analyzed and
group averaged; n denotes the total number of neurons analyzed, as follows:
control/synapsin, n = 16; CST-TKD/synapsin, n = 18; LRRTM-DKD/synapsin,
n = 15; control/VGLUT1, n = 15; CST-TKD/VGLUT1, n = 15; control/GAD67, n =
16; CST-TKD/GAD67, n = 15; control/Homer1, n = 18; CST-TKD/Homer1, n =
21; control/gephyrin, n = 22; and CST-TKD/gephyrin, n = 22).
(G) Representative images of cultured hippocampal neurons infected with a
vector expressing control lentiviruses (control); a vector expressing shRNA
viruses against CST-1, CST-2, and CST-3 (CST-TKD); the CST-TKD vector
together with lentiviruses expressing full-length human CST-1 (denoted as
Rescue [+CST-1]), full-length human CST-3 (denoted as Rescue [+CST-3]), or
both human CST-1 and human CST-3 (denoted as Rescue [+CST-1/3]); or
lentiviruses expressing only full-length human CST-1 (CST-1), full-length
human CST-2 (CST-2), or full-length human CST-3 (CST-3). The neurons were
analyzed through double immunofluorescence using antibodies to MAP2
(blue) and synapsin (red) at DIV14. The scale bar represents 35 mm (applies to
all images).
(H and I) Summary graphs of the effects of the indicated lentiviruses on
synapse density (H; measured using synapsin as a general synapse marker)
and soma size (I; measured using MAP2 signals). Note that lentiviral ex-
pression of CST-3 did not increase synapse density, whereas high-level
overexpression of CST-3 by calcium-phosphate-mediated transfection
significantly increased the synapse density (see Figure S7). The data are
shown as the means ± SEMs (3*p < 0.001; assessed using ANOVA with
Tukey’s test; 2 to 3 dendrites per transfected neuron were analyzed and group
averaged; n denotes the total number of neurons analyzed, as follows: control,
n = 19; CST-TKD, n = 14; CST-TKD+CST-1 rescue, n = 15; CST-TKD+CST-2
rescue, n = 16; CST-TKD+CST-3 rescue, n = 17; CST-TKD+CST-1/3 rescue,
n = 16; CST-1, n = 15; CST-2, n = 22; and CST-3, n = 17).
Figure 5. CST Knockdown Impairs Inhibi-
tory, but Not Excitatory, Synaptic Transmis-
sion In Vivo
(A) In utero electroporation was performed at E15
to transfect neuron precursors with control or
CST-TKD vectors. Coronal brain sections were
prepared at P14–P19. ManyGFP-positive neurons
were detected in layer II/III of somatosensory
cortex. The scale bar represents 250 mm.
(B–D) Effect of CST proteins on inhibitory synaptic
transmission. Representative traces (B) ofmIPSCs
in somatosensory cortical neurons in layer II/III
electroporated in utero with control or CST-TKD
vector. Summary graphs of the frequencies (C)
and amplitudes (D) of mIPSCs in neurons trans-
fected with control or CST-TKD vectors.
(E–G) Effect of CST proteins on excitatory
synaptic transmission. Representative traces (E)
of mEPSCs in somatosensory cortical neurons in
layer II/III electroporated in utero with control
or CST-TKD vector. Summary graphs of the fre-
quencies (F) and amplitudes (G) of mEPSCs in
neurons transfected with control or CST-TKD
vectors.
(H and I) Effect of CST proteins on PPR (amplitude
of the second IPSC divided by that of the first).
Representative traces (H) and summary graph (I)
of PPR measured with 100 ms interstimulus
intervals are shown.
(J and K) Membrane capacitance (J; Cm) and input
resistance (K; Rm) measured in control and
CST-TKD neurons. The data shown in (B–K)
represent the means ± SEMs (*p < 0.05 using
Student’s t test; n denotes the total number of cells
recorded, as follows: mIPSC control, n = 10;
mIPSC CST-TKD, n = 12; mEPSC control, n = 29;
mEPSCCST-TKD, n = 30; PPR control, n = 13; and
PPR CST-TKD, n = 15).CST-3 requires Nrxs for its presynapse-inducing activities but is
indirectly linked to them.
DISCUSSION
Currently, the neural roles of CST-1 have been extensively stud-
ied in the brain, showing that CST-1 is localized to both excit-
atory and inhibitory synapses and forms a tripartite complex
with both Mint/X11 adaptor protein and APP, stabilizing intracel-
lular APP metabolism and thereby suppressing Mint/X11-medi-
ated Ab secretion (Araki et al., 2003; Vogt et al., 2001). Moreover,
CST-1 mediates the transport of axonal APP-containing organ-
elles in a kinesin-1-dependent manner (Konecna et al., 2006;
Vagnoni et al., 2011, 2012). Recently, several genetic studies
have implicated CST-2 polymorphisms in episodic memory
performance, suggesting that CST-2 might regulate cognitive
processes in the brain (Papassotiropoulos et al., 2006; Preusch-
hof et al., 2010). However, the synaptic functions of CST proteins
have not been investigated. Particularly, the functions of CST-3
have been less explored than those of CST-1 and CST-2. The
cadherin superfamily proteins are key regulators of various
neuronal processes but have been generally consideredCedispensable for de novo synapse formation (Scheiffele et al.,
2000; Takeichi, 2007). Instead, these proteins have been sug-
gested as critical for modulating numerous synaptic signaling
pathways and synaptic plasticity (Arikkath and Reichardt,
2008). Here, we demonstrated that the two cadherin repeats of
CST-3 are required for the synaptogenic activity of this protein
(Figure 2). However, it was recently reported that the cadherin
repeats of CST-3 are required, but not sufficient, for the synap-
togenic activity of CST-3 (Pettem et al., 2013), inconsistent
with the results obtained in the present study. Although the
nature of this discrepancy is currently unclear, the surface
expression levels of the plasmids used in these two studies
might differ, leading to completely different conclusions. More-
over, the fact that CSTs possess only two cadherin repeats at
the N terminus is a striking exception in the cadherin superfamily,
as themajority of cadherin proteins possess five or more repeats
(Hulpiau and van Roy, 2009). Furthermore, CST-TKD halted
neuron growth, resulting in smaller soma size (Figures 4 and
S6). Although the roles of cadherin superfamily proteins in
neuron development have been relatively well established, this
study reports that members of this family are directly involved
in the neuron soma development. Importantly, CSTs are amongll Reports 6, 1096–1109, March 27, 2014 ª2014 The Authors 1103
Figure 6. Nrxs Are Functional Receptors for CST-3 to Promote Presynaptic Development
(A) Coomassie-blue-stained gel of recombinant Ig-control (IgC) and Ig-CST-3 (Ig-CST-3) fusion proteins used for affinity chromatography and pull-down
experiments.
(B) Identification of specific CST-3-binding proteins in mouse brains. Solubilized mouse-brain proteins were subjected to pull-down experiments with IgC or
Ig-CST-3-fusion protein. Equivalent amounts of bound proteins were resolved using SDS-PAGE, and the gels were subsequently Coomassie blue stained. The
boxed regions indicate the specific bands unique to the Ig-CST-3-bound fraction, which were further analyzed through mass spectroscopy.
(C and D) Mass spectrometry data. Total ion chromatogram (XIC) of an LC separation from Ig-CST3-bound eluates (C). Extracted ion chromatogram of ion m/z
733.33 and 547.29 from CST-3 (19.30 min) and Nrx-1a (25.77 min; D).
(E and F) The tandem mass spectrometry (MS/MS) spectrum of two double-charged peptides unique for CST-3 and Nrx-1a obtained from liquid chromatog-
raphy-tandem mass spectrometry (LC-MS/MS) at 733.33 and 547.29, fragmented to produce an MS/MS spectrum with b- and c-ion series describing the
sequences ADESWQGTVTDTR (aa 684–696) and SADYVNLALK (aa 327–336).
(G and H) The effect of triple Nrx knockdown (sh-Nrx1/sh-Nrx2/sh-Nrx3) on the synaptogenic activities of CST-3, NL1, and Slitrk1. Representative immuno-
fluorescence images (G) of cocultures stained with antibodies to mVenus or HA (green) and synapsin (red). Coincident signals are indicated in yellow. The scale
bar represents 10 mm (applies to all images). Quantitation (H) of heterologous synapse-formation assays, measured as the ratio of synapsin to mVenus/HA
fluorescence signals. The dashed lines correspond to the control values used as the baseline. The data are shown as themeans ±SEMs (3*p < 0.001 and *p < 0.05
using ANOVA with Tukey’s test; n denotes the total number of HEK293T cells analyzed, as follows: control/sh-control, n = 19; control/sh-Nrx1/sh-Nrx2/sh-Nrx3,
n = 45; CST-3/sh-control, n = 43; CST-3/sh-Nrx1/sh-Nrx2/sh-Nrx3, n = 39; NL1/sh-control, n = 30; NL1/sh-Nrx1/sh-Nrx2/sh-Nrx3, n = 28; Slitrk1/sh-control, n =
24; and Slitrk1/sh-Nrx1/sh-Nrx2/sh-Nrx3, n = 29).a small group of evolutionarily conserved synapse organizers,
including NLs, Nrxs, and leukocyte antigen-related receptor pro-
tein tyrosine phosphatases. In invertebrates, these synapse
organizers have been implicated in neuron development and1104 Cell Reports 6, 1096–1109, March 27, 2014 ª2014 The Authorssynaptic functions (Calahorro and Ruiz-Rubio, 2013; Hu et al.,
2012). CASY-1, theC. elegans ortholog of CSTs, is also essential
for associative learning (Hoerndli et al., 2009; Ikeda et al., 2008);
the Drosophila ortholog of CSTs (Cals) has not yet been












Q9CS84 Nrx-1a neurexin-1a 130 59
Q63374 Nrx-2a neurexin-2a 26 29
Q6P9K9 Nrx-3a neurexin-3a 70 48
Accession numbers refer to the Uniprot/SwissProt database.functionally explored. Because the neuronal expression of hu-
man CST-2 in C. elegans functionally rescues the learning de-
fects of CASY-1mutants, we also examined whether Cals is syn-
aptogenic using heterologous synapse-formation assays.
However, Cals proteins, like CST-1 or CST-2, did not induce pre-
synaptic differentiation (data not shown). Thus, whether the
functional significance of the Nrx/CST interaction reported in
the present study also applies to the other model organisms re-
mains undetermined.
Nrxs are essential for synapse formation and function
(reviewed in Craig and Kang, 2007 and Su¨dhof, 2008). The
coupling of calcium channels to presynaptic machinery inmouse
genetics studies has shown that a-Nrxs are important for presyn-
aptic functions, but not structural integrity (Dudanova et al.,
2007; Missler et al., 2003). The loss of all three a-Nrxs dramati-
cally reduces spontaneous and evoked synaptic transmission
at both excitatory and inhibitory synapses, although the defect
in excitatory synaptic transmission reflects an Nrx-a1 deficiency
(Etherton et al., 2009; Missler et al., 2003). a-Nrxs transsynapti-
cally interacts with a multitude of postsynaptic adhesion mole-
cules, including NLs, LRRTMs, cerebellins, dystroglycans,
latrophilins, and neurexophilins (reviewed in Krueger et al.,
2012). However, because most of these postsynaptic ligands
interact with both a- and b-Nrxs (except neurexophilins), the
functions of these synaptic adhesion pathways cannot be exclu-
sively attributed to a-Nrx-specific synaptic functions. The data
obtained in the present study suggest that CST-3 does not
form a physical complex with Nrxs but requires interactions
with these molecules for synaptogenic activities, suggesting
unidentified ‘‘intermediary’’ proteins that bridge CST-3 and
Nrxs. A recent study reported that a-Nrxs, but not b-Nrxs,
directly interact with CST-3 (Pettem et al., 2013). These authors
presented a series of cell-surface-labeling and pull-down assays
to demonstrate the interaction of CST-3 with a-Nrxs. However,
we did not observe any significant binding of CST-3 to any of
the three a-Nrxs in cell-surface-labeling assays (Figure 7).
Moreover, we found that various deletion variants of Nrx-1a
did not interact with CST-3. Furthermore, we did not observe
any significant enrichment of CSTs with recombinant Nrx-1a
proteins in mouse brain pull-down assays (Figure 7). Overall,
we found no clear-cut evidence to support the direct interaction
of CST-3 with a-Nrxs. Nevertheless, we observed that Nrxs are
essential for CST-3 function because the triple knockdown of
Nrxs significantly reduced the synaptogenic activities of CST-3
(Figure 6). Currently, there is no precise explanation for the
discrepant results between the two papers. Indeed, our data
present two inherent paradoxes that we cannot at presentCeresolve but that paint a very different picture than that proposed
by Pettem et al. (2013). First, in artificial synapse-formation as-
says, only CST-3 is active, but not the other CSTs, whereas
only a combined triple knockdown of all CSTs affects synapse
density. Second, in pull-downs with recombinant CST-3, some
Nrxs were found, and in artificial synapse-formation assays,
the presynaptic Nrx-TKD blocked CST-3-induced synapse
formation, but in all other binding assays, no CST-3 binding to
Nrxs was detected. Most of these data were obtained in our
laboratories before Pettem et al. (2013) was published, but we
did not proceed to publication because we could not rationally
reconcile these results and formulate a coherent conclusion
from them.We do feel, however, that based on our observations,
it is highly unlikely that CSTs are general Nrx ligands analogous
to LRRTMs, neuroligins, or cerebellins.
In the present study, we found that the suppression of multiple
CST isoforms, but not individual CSTs, reduced synapse density,
suggesting redundancy among CST isoforms (Figure 4). How-
ever, electrophysiology experiments in both cultured and in vivo
neurons indicated that CSTs act preferentially to inhibitory syn-
apse structure and function (Figures 5 and S5). These results
are consistent with those from previous reports, showing that
triple-NL loss through acute KD in cultured neurons suppresses
the frequency of mIPSCs (Chih et al., 2005). Moreover, a-Nrx-
specific sequences confer specific activity toward inhibitory
synapses in heterologous synapse-formation assays (Kang
et al., 2008), suggesting thatCST-3might beamajor postsynaptic
mediator of inhibitory synapse organization through a-Nrxs.
Notably, althoughCST-3KD alone did not significantly affect syn-
apse density in cultured neurons (Figure 4), synaptic transmission
might be impaired at specific synapses, as demonstrated for indi-
vidual NL isoforms (Chubykin et al., 2007). Consistently, analyses
ofCST-3-KOmice showed that bothexcitatoryand inhibitorysyn-
aptic transmissions are impaired (Pettem et al., 2013).
Although certain mechanistic details remain unresolved, CSTs
have been predominantly associated with AD pathogenesis
(reviewed in Suzuki et al., 2006). For example, CST-1 modulates
the effects of APP processing and trafficking, and CSTs coaccu-
mulate with APP in dystrophic neuritis. Moreover, CST-1 KD per-
turbs the axonal transport of APP-containing vesicles and alters
APP processing, leading to increased Ab production (Vagnoni
et al., 2012). Furthermore, the proteolytically processed
C-terminal fragment ofCST-3 accumulates indystrophic neurites
surrounding Ab plaques in ADmodelmice, accelerating neuronal
death (Uchida et al., 2013). Intriguingly, CST-1 and CST-3 have
been identified as potential biomarkers of AD (Ringman et al.,
2012; Yin et al., 2009). Recently, several g-secretase mutations
impair Nrx-3b processing, linking Nrxs with AD pathogenesis
(Bot et al., 2011). It is tempting to speculate that themisregulation
of CST-3 and/or Nrx proteolytic processing might induce a
subset of early onset familial AD. It has been suggested that an
imbalance between excitatory and inhibitory synapses is the
central mechanism underlying a multitude of neuropsychiatric
disorders. In the present study, we observed that inhibitory
synapse function is selectively disrupted through CST-TKD in
both cultured and in vivo neurons. Although there are currently
no reports that CSTs are involved in neuropsychiatric disorders,
it is likely that the synaptic dysfunction of CSTs contributesll Reports 6, 1096–1109, March 27, 2014 ª2014 The Authors 1105
Figure 7. Nrxs Do Not Directly Interact with CST-3
(A) Cell-surface-labeling assays. HEK293T cells expressing NL1-mVenus (NL1) or HA-tagged CSTs (CST-1, CST-2, CST-3, or CST-3 Cad) were incubated with
control Ig-fusion proteins (Ig) or IgNrx-1a-1 or IgNrx-1b-1 (Ig-fusion proteins of neurexin-1a and1b, respectively, lacking an insert in splice site No. 4). The cells
were analyzed by immunofluorescence imaging for Ig-fusion proteins (red) and HA/mVenus (green). Representative merged images are shown. The scale bar
represents 10 mm (applies to all images).
(B) Cell surface-labeling assays. HEK293T cells expressing pcDNA3-FLAG-Nrx vectors were incubated with Ig, Ig-CST-3 proteins (Ig-CST-3), or Ig-neuroligin-2
(Ig-NL2). The cells were analyzed by immunofluorescence imaging for Ig-fusion proteins (red) and FLAG (green). The only representative merged images are
shown. The scale bar represents 10 mm (applies to all images).
(legend continued on next page)
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to the pathogenesis of multiple neuropsychiatric disorders.
Intriguingly, CST-1 mRNA levels are upregulated in chronic
cocaine-treated mice, suggesting that CST-1 dysfunction might
be associated with addiction (Yao et al., 2004) via impaired
long-term synaptic plasticity at inhibitory synapses (Niehaus
et al., 2010). Some neuropsychiatric disorders (e.g., schizo-
phrenia, autism, and intellectual disabilities) have been associ-
ated with specific defects in the development and function of in-
terneurons. Considering that CST-2 and CST-3 are highly
expressed in interneurons (Hintsch et al., 2002), it is possible
that themolecular dysfunctions of theseCST isoforms contribute
to these diseases.
In conclusion, we identified CST-3 as a synaptogenic adhe-
sion molecule that forms complexes with Nrxs. Future studies
should identify intermediary protein(s) that functionally bridge
CST-3 and Nrxs, characterize the detailed molecular mecha-
nisms underlying the intracellular transduction of CST-3/Nrxs
extracellular signals, identify the presynaptic receptors for
CST-1 and/or CST-2 to establish a complete understanding of
the synaptic functions of CST proteins, and validate the
functions of CSTs proposed in the current study in vivo.
EXPERIMENTAL PROCEDURES
The Construction of Expression Vectors
HA-CSTs encode full-length mouse CSTs containing an inserted HA-epitope.
The signal peptide sequence of CST-1 (amino acids [aa] 1–28) was initially PCR
amplified, digested with HindIII/BglII, and cloned into the GW1 vector (British
Biotechnology). The remaining CST-1 sequences (aa 29–979) were PCR
amplified, digested with BglII and EcoRI, and cloned into the GW1 vector.
Full-length CST-2 and CST-3, excluding the corresponding signal peptide
sequences (CST-2, aa 21–966; CST-3, aa 20–956), were PCR amplified,
digested with XmaI and SacII, and subcloned into the pDisplay vector
(Invitrogen). pDis-CST-3 deletion variants encode the indicated CST-3 frag-
ment (Cad+LNS, aa 36–541; LNS+linker, aa 335–846; Cad repeats, aa
20–257; LNS, aa 335–541; Cad repeat 1, aa 36–158; and Cad repeat 2, aa
152–259) cloned into the pDisplay vector at XmaI and SacII sites. pDis-Nrxs
encode the indicated Nrx-1a, Nrx-1b, Nrx-2a, or Nrx-3a fragments cloned
into the pDisplay vector at the indicated restriction enzyme sites. To construct
shRNA lentiviral expression vectors, oligonucleotides targeting mouse CST-1,
CST-2, or CST-3 were annealed, phosphorylated, and cloned into the XhoI and
XbaI sites of a single KD vector (L-309 vector; see Figure 4A for a schematic
diagram of vectors) immediately downstream of the human H1 promoter.
For CST-TKD, oligonucleotides targeting CST-1 (J73), CST-2 (J76), and
CST-3 (J81) were subcloned, respectively, into the XhoI-XbaI (J73), BstEII-
BsiWI (J76), and SbfI-BstBI (J81) sites of a TKD vector (L-313 vector) con-
taining two human H1 promoters and two human U6 promoters. For the
details, see the Supplemental Experimental Procedures.
Antibodies
Antibodies used in this study are described in detail in the Supplemental
Information associated with this paper.(C) Domain structures of a- and b-Nrxs (top) and identities of pDisplay-Nrx constru
repeats, neurexins, and sex hormone-binding globulin; E, EGF-like sequences; C
arrows, positions of canonical alternative splice sites (Ullrich et al., 1995). ‘‘’’ corr
corresponds to the large insert (see Sugita et al., 2001). N.A., not applicable.
(D) Cell-surface-labeling assays. HEK293T cells expressing pDis-Nrx-a constru
immunofluorescence imaging for Ig-fusion proteins (red) andHA (green). Represen
images).
(E) Pull-down assays in solubilized mouse synaptosomal fractions. The pull-d
recombinant proteins. Equivalent amounts of bound proteins were analyzed usin
CeHeterologous Synapse-formation Assays, Cell Surface-Labeling
Assays, and Cell-Adhesion Assays
Heterologous synapse-formation assays, cell-surface-labeling assays, and
cell-adhesion assays were performed using HEK293T cells as previously
described (Ko et al., 2009a).Affinity Chromatography and Mass Spectroscopy
Affinity chromatography and mass spectroscopy were performed using
recombinant CST-3 fusion proteins as previously described (Ko et al., 2009a).Production of Recombinant Lentiviruses
Recombinant lentiviruses were produced through the transfection of human
embryonic kidney 293T cells with four plasmids—L-313 vectors (L-313-Nrx-
TKD or L-313 alone), pRRE, pVSVg, and pREV—using FuGENE-6 (Roche) as
previously described (Ko et al., 2011).Primary Neuronal Culture, Transfections, Immunocytochemistry,
Image Acquisition, and Analyses
Primary neuronal culture, transfections, immunohistochemistry, image acqui-
sition, and analyses were performed using E18-derived mouse hippocampal
cultured neurons and confocal microscopy as previously described (Ko
et al., 2009b).In Utero Electroporation
Pregnant ICR mice at 15 days post coitum were anesthetized with an intraper-
itoneal injection of pentobarbital sodium, and the uterine horns were exposed
through a longitudinal incision in the abdomen. Approximately 1 ml of DNA
solution containing 1 mg/ml pCAGGS-EGFP, 1.5 mg/ml L-315-CST-TKD
shRNA, and 0.01% Fast Green in PBS or 1 mg/ml pCAGGS-EGFP,
1.5 mg/ml L-315 control shRNA, and 0.01% Fast Green in PBS was injected
into the lateral ventricle of each embryo through a glass capillary electrode.
The uteri were returned to the peritoneal cavity, and the incisions were sutured.
The operated mice were returned to their home cages and subsequently
allowed to deliver naturally. The transfected pups were identified at P0 by
visualizing the GFP signals through the scalp using a light-emitting diode
penlight (Handy Blue; Reryon).Electrophysiology
Cell culture and slice electrophysiology were performed as previously
described (Ko et al., 2011).Statistics
All data are expressed as the means ± SEM. All experiments were performed
with at least three independent cultures and statistically evaluated using
Student’s t test and one-way ANOVA, with cell numbers as the basis for ‘‘n’’.
Further details are available in the Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.02.010.cts used for binding studies (bottom). SP, signal peptide; LNS, lamin G-domain
HO, carbohydrate attachment site; T, transmembrane region; blue numbered
esponds to the no-insert variant; ‘‘+’’ corresponds to the small insert; and ‘‘++’’
cts were incubated with control Ig or Ig-CST-3. The cells were analyzed by
tativemerged images are shown. The scale bar represents 10 mm (applies to all
own assays were performed using IgC (control), IgNrx-1a-1, or IgNrx-1b-1
g the antibodies indicated on the right side of the panels (input = 5% of total).
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